Introducing a New Polymerase Chain Reaction Panel–Based Cerebrospinal Fluid Evaluation for Encephalitis and Meningitis: Does It Influence Empiric Treatment Duration, Length of Hospital Stay, and Pathogen-Specific Diagnoses?

• by Fabian Sidler, Pascal Bittel, Jonas Marschall, Philipp Jent

• April 24, 2025

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study

• by Gerome Vallejos, Carla Kim, Kathryn B Holroyd, Kiran T Thakur

• December 11, 2025

Epstein-Barr Virus Central Nervous System Infections and Mortality Risk in Patients Presenting With Suspected Meningitis: Results From the Botswana National Meningitis Survey and the Harare Meningitis Aetiology Study

• by Jayne Ellis, James Milburn, Kebatshabile Ngoni, Christopher G Williams, Charles Muthoga, Taddy Mwarumba, Ezekiel Gwakuba, George Manenji, Rachita Suresh, Tichoaya Machiya, Janet Thubuka, Cassie Northcott, James Penney, Matthew Kinsella, Imogen Mechie, Samuel Ensor, Tshepo Leeme, Leah Owen, Hannah Barton, Keatlaretse Siamisang, Mark W Tenforde, William Hurt, Ronan Doyle, Daniel Grint, Síle F Molloy, Thomas S Harrison, David M Goldfarb, Madisa Mine, Margaret Mokomane, Gift Ngwende, Lenon Gwaunza, Tiny Mazhani, Chiratidzo Ndhlovu, Joseph N Jarvis

• October 23, 2025